CLINICAL ENCOUNTER NOTE
Patient: Thomas Mitchell
Date: 2023-04-16
Provider: Dr. James Chen

CHIEF COMPLAINT:
Shortness of breath, fever, chest pain, and cough for 3 days.

HISTORY OF PRESENT ILLNESS:
65-year-old male with history of hypertension and type 2 diabetes presenting with worsening shortness of breath, persistent fever, chest pain, and productive cough for the past 3 days. Reports temperature up to 101.5°F at home. Describes chest pain as constant, moderate in intensity, non-radiating, and worse with coughing and deep breathing. Progressive dyspnea over the past 24 hours, now occurring with minimal exertion. Patient lives in a nursing home where several residents have recently tested positive for COVID-19. Fully vaccinated against COVID-19 but has not received a booster.

PAST MEDICAL HISTORY:
Hypertension (diagnosed 12 years ago)
Type 2 Diabetes (diagnosed 8 years ago)
Osteoarthritis (knees)
S/P cholecystectomy (2010)

MEDICATIONS:
Lisinopril 20mg daily
Metformin 1000mg BID
Glipizide 5mg daily
Acetaminophen 500mg PRN for pain
Aspirin 81mg daily

ALLERGIES:
Penicillin (rash)

PHYSICAL EXAMINATION:
Vitals: Temp 100.9°F, HR 105, BP 145/90, RR 24, O2 Sat 88% on room air, 94% on 2L O2 via nasal cannula
General: Elderly male in moderate respiratory distress. Alert but fatigued.
HEENT: Oropharynx clear. No nasal discharge.
Neck: Supple. No JVD. No lymphadenopathy.
Lungs: Diffuse crackles bilaterally, more pronounced at bases. No wheezing.
Cardiovascular: Tachycardic. Regular rhythm. No murmurs.
Abdomen: Soft, non-tender, non-distended.
Extremities: Trace bilateral lower extremity edema. No cyanosis.
Neuro: Alert and oriented to person, place, and time. No focal neurological deficits.

LABORATORY DATA:
CBC: WBC 12.4 (elevated), Lymphocytes 0.6 (decreased), Hemoglobin 13.1, Platelets 180
CMP: Glucose 245, otherwise within normal limits
CRP: 78.3 (markedly elevated)
D-dimer: 1.2 (elevated)
Ferritin: 645 (elevated)
Procalcitonin: 0.8
COVID-19 PCR: Pending
Chest X-ray: Bilateral patchy infiltrates consistent with viral pneumonia

ASSESSMENT:
1. Acute hypoxic respiratory failure due to suspected COVID-19 pneumonia
2. Hypertension, poorly controlled
3. Type 2 Diabetes mellitus, poorly controlled

PLAN:
1. Admit to COVID-19 unit for management of hypoxic respiratory failure
2. Supplemental oxygen to maintain SpO2 > 94%
3. Start remdesivir and dexamethasone per COVID-19 protocol
4. IV fluids for hydration
5. Empiric ceftriaxone and azithromycin pending cultures
6. Continue home medications with adjustment of insulin regimen
7. Deep vein thrombosis prophylaxis
8. Monitor for clinical deterioration
9. Pulmonology consult
10. Discussed case with nursing home for contact tracing

Patient understands the severity of his condition and the need for hospitalization.